Ten years on: Mediation of cell death by the common neurotrophin receptor p75NTR

Cytokine and Growth Factor Reviews

Volumn 14, Issue 3-4, 2003, Pages 225-239

  Rabizadeh, Shahrooz ^a   Bredesen, Dale E ^a,b  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Critical phase; Death domain; Dependence receptor; Neuronal development

Indexed keywords

FAS LIGAND; NEUROTROPHIN; NEUROTROPHIN RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; CELL DEATH; CELL MATURATION; CELL SURVIVAL; GENE CONTROL; GENE FUNCTION; LIGAND BINDING; NERVE ENDING; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

EID: 0038659005     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(03)00018-2     Document Type: Review

References (142)

1. Levi-Montalcini R, Levi G. Les conséquences de la destruction d'un territoire d'innervation périphérique sur le développement des centres nerveux correspondent dans l'embryon de poulet. Arch Biol 1942;53:537-45.
2. Hamburger V, Levi-Montalcini R. Proliferation, differentiation, and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zool 1949;111:457-502.
3. Hamburger V. The effects of wing bud extirpation on the development of the central nervous system in chick embryos. J Exp Zool 1934;68:449-94.
4. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-62.
5. Bueker ED. Implantation of tumors in the hind limb field of the embryonic chick and the developmental response of the lumbo-sacral nervous system. Anat Rec 1948;102:369-90.
6. Levi-Montalcini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool 1951;116:321-61.
7. Cohen S, Levi-Montalcini R, Hamburger V. A nerve growth-stimulating factor isolated from sarcomas 37 and 180. Proc Natl Acad Sci USA 1954;40:1014-8.
8. Cohen S. Purification of a nerve growth factor promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum. Proc Natl Acad Sci USA 1960;46:302-11.
9. Levi-Montalcini R, Booker B. Destruction of the sympathetic ganglia in mammals by an anti-serum to the nerve growth factor. Proc Natl Acad Sci USA 1960;46:384-91.
10. Campenot RB. Local control of neurite development by nerve growth factor. Proc Natl Acad Sci USA 1977;74:4516-9.
11. Varon S, Nomura J, Shooter EM. Subunit structure of a high-molecular-weight form of the nerve growth factor from mouse submaxillary gland. Proc Natl Acad Sci USA 1967;57:1782-9.
12. Benedetti M, Levi A, Chao MV. Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc Natl Acad Sci USA 1993;90:7859-63.
13. Angeletti PU, Levi-Montalcini R, Caramia F. Ultrastructural changes in sympathetic neurons of newborn and adult mice treated with nerve growth factor. J Ultrastruct Res 1971;36:24-36.
14. Snider WD. Nerve growth factor enhances dendritic arborization of sympathetic ganglion cells in developing mammals. J Neurosci 1988;8:2628-34.
15. Thoenen H, Angeletti PU, Levi-Montalcini R, Kettler R. Selective induction by nerve growth factor of tyrosine hydroxylase and dopamine-hydroxylase in the rat superior cervical ganglia. Proc Natl Acad Sci USA 1971;68:1598-602.
16. Kessler JA, Black IB. Similarities in development of substance P and somatostatin in peripheral sensory neurons: effects of capsaicin and nerve growth factor. Proc Natl Acad Sci USA 1981;78:4644-7.
17. Otten U, Lorez HP. Nerve growth: factor increases substance P, cholecystokinin and vasoactive intestinal polypeptide immunoreactivities in primary sensory neurones of newborn rats. Neurosci Lett 1982;34:153-8.
18. Snider WD, Johnson Jr EM. Neurotrophic molecules. Ann Neurol 1989;26:489-506.
19. Shelton D, Reichardt L. Studies on the expression of the nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF and mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons. Proc Natl Acad Sci USA 1986;83:2714-8.
20. Seiler M, Schwab ME. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res 1984;300:33-9.
21. Levi-Montalcini R, Hamburger V. A diffusible agent of mouse sarcoma. J Exp Zool 1953;123:233-87.
22. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 1986;6:2155-62.
23. Sofroniew MV, Galletly NP, Isacson O, Svendsen CN. Survival of adult basal forebrain cholinergic neurons after loss of target neurons. Science 1990;247:338-42.
24. Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Bjorklund A, et al. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fomix transection. Proc Natl Acad Sci USA 1986;83:9231-5.
25. Taniuchi M, Clark HB, Johnson Jr EM. Induction of nerve growth factor receptor in Schwann cells after axotomy. Proc Natl Acad Sci USA 1986;83:4094-8.
26. Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982;1:549-53.
27. Snider WD. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 1994;77:627-38.
28. Hofer MM, Barde YA. Brain-derived neurotrophic factor prevents neuronal death in vivo. Nature 1988;331:261-2.
29. McKay SE, Garner A, Caldero J, Tucker RP, Large T, Oppenheim RW. The expression of trkB and p75 and the role of BDNF in the developing neuromuscular system of the chick embryo. Development 1996;122:715-24.
30. Jones KR, Farinas I, Backus C, Reichardt LF. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 1994;76:989-99.
31. Baimbridge KG, Celio MR, Rogers JH. Calcium-binding proteins in the nervous system. Trends Neurosci 1992;15:303-8.
32. Hohn A, Leibrock J, Bailey K, Barde YA. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 1990;344:339-41.
33. Hory-Lee F, Russell M, Lindsay RM, Frank E. Neurotrophin-3 supports the survival of developing muscle sensory neurons in culture. Proc Natl Acad Sci USA 1993;90:2613-7.
34. Ernfors P, Lee KF, Kucera J, Jaenisch R. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 1994;77:503-12.
35. Barres BA, Raff MC. Control of oligodendrocyte number in the developing rat optic nerve. Neuron 1994;12:935-42.
36. Ip NY, Stitt TN, Tapley P, Klein R, Glass DJ, Fandl J, et al. Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron 1993;10:137-49.
37. Funakoshi H, Belluardo N, Arenas E, Yamamoto Y, Casabona A, Persson H, et al. Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science 1995;268:1495-9.
38. Chao MV, Bothwell MA, Ross AH, Koprowski H, Lanahan AA, Buck CR, et al. Gene transfer and molecular cloning of the human NGF receptor. Science 1986;232:518-21.
39. Radeke MJ, Misko TP, Hsu C, Herzenberg LA, Shooter EM. Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 1987;325:593-7.
40. Klein R, Jing S, Nanduri V, O'Rourke E, Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 1991;85:189-97.
41. Klein R, Nanduri V, Jing SA, Lamballe F, Tapley P, Bryant S, et al. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 1991;66:395-403.
42. Lamballe F, Klein R, Barbacid M. trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 1991;66:967-79.
43. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 1991;350:678-83 [see comments].
44. Hosang M, Shooter EM. Molecular characteristics of nerve growth factor receptors on PC12 cells. J Biol Chem 1985;260:655-62.
45. Chao MV. The p75 neurotrophin receptor. J Neurobiol 1994;25: 1373-85.
46. NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. J Neurosci 1997;17:7594-605.
47. NTR leads to long-lasting increases in the number of basal forebrain. J Neurosci 2002;22:2409-18.
48. Yaar M, Zhai S, Pilch PF, Doyle SM, Eisenhauer PB, Fine RE, et al. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest 1997;100:2333-40.
49. Perini G, Della-Bianca V, Politi V, Della Valle G, Dal-Pra I, Rossi F, et al. Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med 2002;195:907-18.
50. Yaar M, Zhai S, Fine RE, Eisenhauer PB, Arble BL, Stewart KB, et al. Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J Biol Chem 2002;277:7720-5.
51. Langevin C, Jaaro H, Bressanelli S, Fainzilber M, Tuffereau C. Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor. J Biol Chem 2002;277:37655-62.
52. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002;420:74-8.
53. Rabizadeh S, Oh J, Zhong LT, Yang J, Bitler CM, Butcher LL, et al. Induction of apoptosis by the low-affinity NGF receptor. Science 1993;261:345-8.
54. Salehi AH, Roux PP, Kubu CJ, Zeindler C, Bhakar A, Tannis LL, et al. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 2000;27:279-88.
55. NTR. J Biol Chem 2000;275:17566-70.
56. NTR and participates in programmed cell death. EMBO J 1999;18:6050-61.
57. Khursigara G, Bertin J, Yano H, Moffett H, DiStefano PS, Chao MV. A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2. J Neurosci 2001;21:5854-63.
58. Ye X, Mehlen P, Rabizadeh S, VanArsdale T, Zhang H, Shin H, et al. TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J Biol Chem 1999;274:30202-8.
59. NTR and their effect on NF-kappaB activation. FEBS Lett 1999;460:191-8.
60. NTR. EMBO J 1999;18:616-22.
61. NTR. J Neurosci Res 2000;60:587-93.
62. Frankowski H, Castro-Obregon S, del Rio G, Rao RV, Bredesen DE. PLAIDD, a type II death domain protein that interacts with p75 neurotrophin receptor. J Neuromol Med 2002;1:153-70.
63. Barker PA, Barbee G, Misko TP, Shooter EM. The low affinity neurotrophin receptor, p75LNTR, is palmitoylated by thioester formation through cysteine 279. J Biol Chem 1994;269:30645-50.
64. Liepinsh E, Ilag LL, Otting G, Ibanez CF. NMR structure of the death domain of p75 neurotrophin receptor. EMBO J 1997;16:4999-5005.
65. Feinstein DL, Larhammar D. Identification of a conserved protein motif in a group of growth factor receptors. FEBS Lett 1990;272:7-11.
66. Myers SM, Ross GM, Dostaler SM, Anderson MN, Weaver DF, Riopelle RJ. Putative cytoplasmic amphiphilic domains in the nerve growth factor/tumour necrosis factor receptor superfamily. Biochim Biophys Acta 1994;1196:21-8.
67. Rabizadeh S, Ye X, Sperandio S, Wang JJ, Ellerby HM, Ellerby LM, et al. Neurotrophin dependence domain: a domain required for the mediation of apoptosis by the p75 neurotrophin receptor. J Mol Neurosci 2000;15:215-29.
68. Chen EY, Mufson EJ, Kordower JH. TRK and p75 neurotrophin receptor systems in the developing human brain. J Comp Neurol 1996;369:591-618.
69. Schatteman GC, Langer T, Lanahan AA, Bothwell MA. Distribution of the 75-kDa low-affinity nerve growth factor receptor in the primate peripheral nervous system. Somatosens Mot Res 1993;10:415-32.
70. NTR and Trk receptors are expressed in reciprocal patterns in a wide variety of non-neural tissues during rat embryonic development, indicating independent receptor functions. J Comp Neurol 1998;391:407-28.
71. Wheeler EF, Bothwell M. Spatiotemporal patterns of expression of NGF and the low-affinity NGF receptor in rat embryos suggest functional roles in tissue morphogenesis and myogenesis. J Neurosci 1992;12:930-45.
72. Pflug BR, Onoda M, Lynch JH, Djakiew D. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res 1992;52:5403-6.
73. Torcia M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, Rubartelli A, et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996;85:345-56.
74. Chinnaiyan AM, Dixit VM. Portrait of an executioner: the molecular mechanism of FAS/APO-1-induced apoptosis. Semin Immunol 1997;9:69-76.
75. Yang X, Khosravi-Far R, Chang HY, Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997;89:1067-76.
76. Cahill MA, Peter ME, Kischkel FC, Chinnaiyan AM, Dixit VM, Krammer PH, et al. CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene 1996;13:2087-96.
77. NTR apoptotic signaling pathway using a novel cellular model. J Biol Chem 2001;276:33812-20.
78. Huang B, Eberstadt M, Olejniczak ET, Meadows RP, Fesik SW. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 1996;384:638-41.
79. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV. A novel domain within the 55 kDa TNF receptor signals cell death. Cell 1993;74:845-53.
80. Coulson EJ, Reid K, Baca M, Shipham KA, Hulett SM, Kilpatrick TJ, et al. Chopper, a new death domain of the p75 neurotrophin receptor that mediates rapid neuronal cell death. J Biol Chem 2000;275:30537-45.
81. Sato T, Irie S, Kitada S, Reed JC. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 1995;268:411-5.
82. Chapman BS. A region of the 75 kDa neurotrophin receptor homologous to the death domains of TNFR-I and Fas. FEBS Lett 1995;374:216-20.
83. Barbacid M. The Trk family of neurotrophin receptors. J Neurobiol 1994;25:1386-403.
84. Jing S, Tapley P, Barbacid M. Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron 1992;9:1067-79.
85. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994;124:619-26.
86. Raff MC. Social controls on cell survival and cell death. Nature 1992;356:397-400.
87. Girard D, Paquin R, Beaulieu AD. Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis. Biochem J 1997;325:145-53.
88. Yan GM, Ni B, Weller M, Wood KA, Paul SM. Depolarization or glutamate receptor activation blocks apoptotic cell death of cultured cerebellar granule neurons. Brain Res 1994;656:43-51.
89. NTR and the concept of cellular dependence: seeing how the other half die. Cell Death Differ 1998;5:365-71 [see comments].
90. Martin DP, Schmidt RE, deStefano PS, Lowry OH, Carter JG, Johnson EM. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 1988;106:829-44.
91. Korsching S, Thoenen H. Quantitative demonstration of the retrograde axonal transport of endogenous nerve growth factor. Neurosci Lett 1983;39:1-4.
92. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991;14:453-501.
93. Hamburger V. Cell death in the development of the lateral motor column of the chick embryo. J Comp Neurol 1975;160:535-46.
94. Emsberger U, Edgar D, Rohrer H. The survival of early chick sympathetic neurons in vitro is dependent on a suitable substrate but independent of NGF. Dev Biol 1989;135:250-62.
95. Davies AM, Bandtlow C, Heumann R, Korsching S, Rohrer H, Thoenen H. Timing and site of nerve growth factor synthesis in developing skin in relation to innervation and expression of the receptor. Nature 1987;326:353-8.
96. Davies AM. The role of neurotrophins in the developing nervous system. J Neurobiol 1994;25:1334-48.
97. Lockshin RA, Williams CM. Programmed cell death. II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths. J Insect Physiol 1964;10:643-9.
98. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
99. Kerr JFR, Harmon BV. Definition and incidence of apoptosis: an historical perspective. In: Tomei LD, Cope FO, editors. Apoptosis: the molecular basis of cell death. Plainview, NY: Cold Spring Harbor Laboratory Press; 1991. p. 321.
100. Yao R, Cooper GM. Requirement for phosphatiylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995;267:2003-6.
101. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997;275:628-30.
102. Rabizadeh S, Bredesen DE. Is p75NGFR involved in developmental neural cell death? Dev Neurosci 1994;16:207-11.
103. Barrett GL, Bartlett PF. The p75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc Natl Acad Sci USA 1994;91:6501-5.
104. Barrett GL, Georgiou A. The low-affinity nerve growth factor receptor p75NGFR mediates death of PC12 cells after nerve growth factor withdrawal. J Neurosci Res 1996;45:117-28.
105. NTR and apoptosis: Trk-dependent and Trk-independent effects. Trends Neurosci 1997;20:287-90.
106. Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 1998;395:801-4.
107. Ellerby LM, Hackam AS, Propp SS, Ellerby HM, Rabizadeh S, Cashman NR, et al. Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity. J Neurochem 1999;72:185-95.
108. Forcet C, Ye X, Granger L, Corset V, Shin H, Bredesen DE, et al. The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc Natl Acad Sci USA 2001;98:3416-21.
109. Bordeaux MC, Forcet C, Granger L, Corset V, Bidaud C, Billaud M, et al. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J 2000;19:4056-63.
110. Llambi F, Causeret F, Bloch-Gallego E, Mehlen P. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J 2001;20:2715-22.
111. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA, Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 2001;155:459-70.
112. Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science 2001;294:1945-8.
113. Bredesen DE. Neuronal apoptosis: genetic and biochemical modulation. In: Apoptosis II: the molecular basis of apoptosis in disease. Plainview, NY: Cold Spring Harbor Laboratory Press; 1994, p. 397-421.
114. Mah SP, Zhong LT, Liu Y, Roghani A, Edwards RH, Bredesen DE. The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J Neurochem 1993;60:1183-6.
115. Kayalar C, Ord T, Testa MP, Zhong LT, Bredesen DE. Cleavage of actin by interleukin 1 β-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci USA 1996;93:2234-8.
116. Bredesen DE. Keeping neurons alive: the molecular control of apoptosis. Part I. In: The neuroscientist. 1996. p. 181-90.
117. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997;91:443-6.
118. Bredesen DE. Keeping neurons alive: the molecular control of apoptosis. Part II. In: The neuroscientist. 1996. p. 211-6.
119. Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 2000;97:14376-81.
120. Frade JM, Rodriguez-Tebar A, Barde YA. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996;383:166-8.
121. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996;383:716-9.
122. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-43.
123. Rabizadeh S, Gralla EB, Borchelt DR, Gwinn R, Valentine JS, Sisodia S, et al. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA 1995;92:3024-8.
124. Bunone G, Mariotti A, Compagni A, Morandi E, Valle GD. Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells. Oncogene 1997;14:1463-70.
125. Taglialatela G, Hibbert CJ, Hutton LA, Werrbach-Perez K, Perez-Polo J. Suppression of p140trkA does not abolish nerve growth factor-mediated rescue of serum-free PC12 cells. J Neurochem 1996;66:1826-35.
126. NTR gene attenuates septal cholinergic cell loss in mice heterozygous for a deletion of the NGF gene. Soc Neurosci Abstr 1996;22:513.
127. NTR: contrast between rescue by BDNF and NGF. Cell Death Differ 1999;6:1222-7.
128. Spencer DM, Belshaw PJ, Chen L, Ho SN, Randazzo F, Crabtree GR, et al. Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization. Curr Biol 1996;6:839-47.
129. Longo FM, Manthorpe M, Xie YM, Varon S. Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism. J Neurosci Res 1997;48:1-17.
130. Wang JJ, Tasinato A, Ethell DW, Testa MP, Bredesen DE. Phosphorylation of the common neurotrophin receptor p75 by p38β2 kinase affects NF-κB and AP-1 activities. J Mol Neurosci 2000;15:19-29.
131. Aloyz RS, Bamji SX, Pozniak CD, Toma JG, Atwal J, Kaplan DR, et al. p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J Cell Biol 1998;143:1691-703.
132. Mukai J, Shoji S, Kimura MT, Okubo S, Sano H, Suvanto P, et al. Structure-function analysis of NADE: identification of regions that mediate nerve growth factor-induced apoptosis. J Biol Chem 2002;277:13973-82.
133. Taglialatela G, Werrbach-Perez K, Perez-Polo R. Effect of p140trkA suppression of NGF and BDNF rescue of apoptotic PC12 cells. Soc Neurosci Abstr 1995;21:1061.
134. Frade JM, Bovolenta P, Martinez-Morales JR, Arribas A, Barbas JA, Rodriguez-Tebar A. Control of early cell death by BDNF in the chick retina. Development 1997;124:3313-20.
135. Palmada M, Kanwal S, Rutkoski NJ, Gufstafson-Brown C, Johnson RS, Wisdom R, et al. c-jun is essential for sympathetic neuronal death induced by NGF withdrawal but not by p75 activation. J Cell Biol 2002;158:453-61.
136. Casaccia-Bonnefil P, Gu C, Khursigara G, Chao MV. p75 neurotrophin receptor as a modulator of survival and death decisions. Microsc Res Tech 1999;45:217-24.
137. Roux PP, Bhakar AL, Kennedy TE, Barker PA. The p75 neurotrophin receptor activates Akt (protein kinase B) through a phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 2001;276:23097-104.
138. Zhai S, Yaar M, Doyle SM, Gilchrest BA. Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating bcl-2 levels. Exp Cell Res 1996;224:335-43.
139. Averback P. Lesions of the nucleus ansae peduncularis in neuropsychiatric disease. Arch Biochem Biophys 1981;38:230-5.
140. NTR-null mutant mice. Circ Res 2002;91:494-500.
141. Cortazzo MH, Kassis ES, Sproul KA, Schor NF. Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: the role of the low-affinity NGF receptor. J Neurosci 1996;16:3895-9.
142. Yan C, Liang Y, Nylander KD, Wong J, Rudavsky RM, Saragovi HU, et al. p75-nerve growth factor as an antiapoptotic complex: independence versus cooperativity in protection from enediyne chemotherapeutic agents. Mol Pharmacol 2002;61:710-9.